These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12649549)

  • 1. Salt restriction and not length of dialysis is the key to drug free blood pressure control in ESRD patients.
    Shaldon S
    J Nephrol; 2003; 16(1):159. PubMed ID: 12649549
    [No Abstract]   [Full Text] [Related]  

  • 2. The long forgotten salt factor and the benefits of using a 5-g-salt-restricted diet in all ESRD patients.
    Shaldon S; Vienken J
    Nephrol Dial Transplant; 2008 Jul; 23(7):2118-20. PubMed ID: 18403433
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in right ventricular pressures during haemodialysis recorded with an implantable haemodynamic monitor.
    Braunschweig F; Kjellström B; Söderhäll M; Clyne N; Linde C
    Nephrol Dial Transplant; 2006 Jan; 21(1):176-83. PubMed ID: 16144845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing dry weight and hypertension in dialysis patients: still a challenge for the nephrologist in 2009?
    Chazot C
    J Nephrol; 2009; 22(5):587-97. PubMed ID: 19809991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging.
    Stewart GA; Mark PB; Johnston N; Foster JE; Cowan M; Rodger RS; Dargie HJ; Jardine AG
    Clin Physiol Funct Imaging; 2004 Nov; 24(6):387-93. PubMed ID: 15522049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should hypertension be assessed and managed in hemodialysis patients? Home BP, not dialysis unit BP, should be used for managing hypertension.
    Agarwal R
    Semin Dial; 2007; 20(5):402-5. PubMed ID: 17897244
    [No Abstract]   [Full Text] [Related]  

  • 8. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?
    Malyszko J; Malyszko J; Wolczynski S; Mysliwiec M
    Nephrol Dial Transplant; 2006 Jan; 21(1):145-52. PubMed ID: 16141459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac troponin T and end stage renal disease.
    Gabr AE; Ibrahim IA; Aloulou SM; Al-Alfi MA; Al-Abdlrahim KA
    Saudi Med J; 2004 Aug; 25(8):1015-9. PubMed ID: 15322590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure control in haemodialysis patients: an audit.
    Al-Hilali N; Al-Humoud H; Ninan VT; Nampoory MR; Johny KV
    Nephrology (Carlton); 2006 Apr; 11(2):100-4. PubMed ID: 16669969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study.
    De Nicola L; Minutolo R; Zamboli P; Cestaro R; Marzano L; Giannattasio P; Cristofano C; Chimienti S; Savica V; Bellinghieri G; Rapisarda F; Fatuzzo P; Conte G;
    Semin Nephrol; 2005 Nov; 25(6):425-30. PubMed ID: 16298267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The internist's role in treating hypertension in hemodialysis patients.
    Hirsch S
    QJM; 2009 Jul; 102(7):501-7. PubMed ID: 19383610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of toxic metals in blood and urine samples of chronic renal failure patients, before and after dialysis.
    Kazi TG; Jalbani N; Kazi N; Jamali MK; Arain MB; Afridi HI; Kandhro A; Pirzado Z
    Ren Fail; 2008; 30(7):737-45. PubMed ID: 18704823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension control with daily dialysis.
    Saad E; Charra B; Raj DS
    Semin Dial; 2004; 17(4):295-8. PubMed ID: 15250921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis.
    Kayikcioglu M; Tumuklu M; Ozkahya M; Ozdogan O; Asci G; Duman S; Toz H; Can LH; Basci A; Ok E
    Nephrol Dial Transplant; 2009 Mar; 24(3):956-62. PubMed ID: 19004849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left-ventricular diastolic dysfunction as a risk factor for dialytic hypotension.
    Rostoker G; Griuncelli M; Loridon C; Benmaadi A; Illouz E
    Cardiology; 2009; 114(2):142-9. PubMed ID: 19521079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in blood pressure measurement in patients treated with maintenance hemodialysis.
    Roberts MA; Pilmore HL; Tonkin AM; Garg AX; Pascoe EM; Badve SV; Cass A; Ierino FL; Hawley CM;
    Am J Kidney Dis; 2012 Sep; 60(3):463-72. PubMed ID: 22704141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension in dialysis and kidney transplant patients.
    Prasad GV; Ruzicka M; Burns KD; Tobe SW; Lebel M
    Can J Cardiol; 2009 May; 25(5):309-14. PubMed ID: 19417862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.